News
MLAB
102.65
+1.62%
1.64
Mesa Laboratories Q1 Adj. EPS $2.68 Beats $0.03 Estimate, Sales $60.138M Miss $60.867M Estimate
Benzinga · 1h ago
Press Release: Mesa Labs Announces First Quarter Results
Dow Jones · 1h ago
*Mesa Labs 1Q Rev $60.1M >MLAB
Dow Jones · 1h ago
*Mesa Labs 1Q EPS 49c >MLAB
Dow Jones · 1h ago
*Mesa Labs 1Q Net $2.83M >MLAB
Dow Jones · 1h ago
Weekly Report: what happened at MLAB last week (0803-0807)?
Weekly Report · 12h ago
Weekly Report: what happened at MLAB last week (0727-0731)?
Weekly Report · 08/03 09:05
Weekly Report: what happened at MLAB last week (0720-0724)?
Weekly Report · 07/27 09:05
Weekly Report: what happened at MLAB last week (0713-0717)?
Weekly Report · 07/20 09:05
Weekly Report: what happened at MLAB last week (0706-0710)?
Weekly Report · 07/13 09:05
Mesa Laboratories And 2 Other Companies That May Be Priced Below Their Estimated Value
Simply Wall St · 07/07 17:07
Mesa Laboratories declares $0.16 dividend
Seeking Alpha · 07/06 15:25
Weekly Report: what happened at MLAB last week (0629-0703)?
Weekly Report · 07/06 09:06
MESA LABS DECLARES QUARTERLY DIVIDEND
Barchart · 07/06 08:50
Weekly Report: what happened at MLAB last week (0622-0626)?
Weekly Report · 06/29 09:05
Weekly Report: what happened at MLAB last week (0615-0619)?
Weekly Report · 06/22 09:06
Mesa Laboratories Executives Quietly Unload Significant Stock Holdings
TipRanks · 06/18 02:07
Mesa Laboratories Promotes Lyndsey Crennen to Chief Accounting Officer
TipRanks · 06/15 23:08
Weekly Report: what happened at MLAB last week (0608-0612)?
Weekly Report · 06/15 09:06
Weekly Report: what happened at MLAB last week (0601-0605)?
Weekly Report · 06/08 09:06
More
Webull provides a variety of real-time MLAB stock news. You can receive the latest news about Mesa Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About MLAB
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.